| __timestamp | Intra-Cellular Therapies, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10337679 | 9335772 |
| Thursday, January 1, 2015 | 18187286 | 12390000 |
| Friday, January 1, 2016 | 24758063 | 25602000 |
| Sunday, January 1, 2017 | 23666957 | 21262000 |
| Monday, January 1, 2018 | 30099855 | 28430000 |
| Tuesday, January 1, 2019 | 64947625 | 40849000 |
| Wednesday, January 1, 2020 | 186363444 | 60210000 |
| Friday, January 1, 2021 | 272611040 | 83664000 |
| Saturday, January 1, 2022 | 358782000 | 104097000 |
| Sunday, January 1, 2023 | 409864000 | 106916000 |
Unleashing insights
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Intra-Cellular Therapies, Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, Intra-Cellular Therapies saw a staggering increase in SG&A expenses, growing nearly 40 times from 2014 to 2023. In contrast, Iovance Biotherapeutics experienced a more modest growth, with expenses increasing by about 11 times.
In 2023, Intra-Cellular Therapies' SG&A expenses reached approximately 410 million, while Iovance Biotherapeutics' expenses were around 107 million. This significant difference highlights the varying strategies and scales of operation between the two companies. As the biotech industry continues to evolve, understanding these financial trends provides valuable insights into the operational priorities and growth trajectories of these innovative firms.
Breaking Down SG&A Expenses: Johnson & Johnson vs Intra-Cellular Therapies, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Intra-Cellular Therapies, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Catalent, Inc.
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Corcept Therapeutics Incorporated
Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Veracyte, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Soleno Therapeutics, Inc. or Iovance Biotherapeutics, Inc.